Export 106 results:
Autore Titolo [ Tipo(Asc)] Anno
Filtri: First Letter Of Title è M  [Clear All Filters]
Journal Article
Zito G, Luppi S, Giolo E, Martinelli M, Venturin I, Di Lorenzo G, Ricci G. Medical treatments for endometriosis-associated pelvic pain. Biomed Res Int 2014;2014:191967.
Girardi D, Falco A, De Carlo A, Benevene P, Comar M, Tongiorgi E, Bartolucci GBattista. The mediating role of interpersonal conflict at work in the relationship between negative affectivity and biomarkers of stress. J Behav Med 2015;38(6):922-31.
Bouchè C, Wiesenfeld U, Ronfani L, Simeone R, Bogatti P, Skerk K, Ricci G. Meconium-stained amniotic fluid: a risk factor for postpartum hemorrhage. Ther Clin Risk Manag 2018;14:1671-1675.
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):2091-2138.
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 2018;391(10136):2236-2271.
Gasparini C, Tommasini A, Zauli G. The MDM2 inhibitor Nutlin-3 modulates dendritic cell-induced T cell proliferation. Hum Immunol 2012;73(4):342-5.
Desai S, Wood-Trageser M, Matic J, Chipkin J, Jiang H, Bachelot A, Dulon J, Sala C, Barbieri C, Cocca M, Toniolo D, Touraine P, Witchel S, Rajkovic A. MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency. J Clin Endocrinol Metab 2017;102(2):576-582.
Secchiero P, Melloni E, Voltan R, Norcio A, Celeghini C, Zauli G. MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. Br J Haematol 2012;157(4):510-4.
Zupin L, Polesello V, Casalicchio G, Freato N, Maestri I, Comar M, Crovella S, Segat L. MBL2 polymorphisms in women with atypical squamous cells of undetermined significance. J Med Virol 2015;87(5):851-9.
Segat L, Crovella S. MBL2 polymorphisms and the choice of controls for association studies: just another story?. Int J Immunogenet 2011;38(2):101-4; author reply 105-8.
Zupin L, Polesello V, Alberi G, Moratelli G, Crocè SL, Masutti F, Pozzato G, Crovella S, Segat L. MBL2 Genetic Variants in HCV Infection Susceptibility, Spontaneous Viral Clearance and Pegylated Interferon Plus Ribavirin Treatment Response. Scand J Immunol 2016;84(1):61-9.
Zupin L, Polesello V, Segat L, Kuhn L, Crovella S. MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia. Immunol Res 2016;64(3):775-84.

Amministrazione Trasparente